Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations
Purpose. Medical cannabis for patients with chronic noncancer pain (CNCP) has been the focus of numerous health care recommendations. We conducted a systematic review to identify and summarize the currently available evidence-based recommendations. Methods. We searched MEDLINE, EMBASE, PsycINFO, the...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2021/8857948 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550834286624768 |
|---|---|
| author | Yaping Chang Meng Zhu Christopher Vannabouathong Raman Mundi Roland S. Chou Mohit Bhandari |
| author_facet | Yaping Chang Meng Zhu Christopher Vannabouathong Raman Mundi Roland S. Chou Mohit Bhandari |
| author_sort | Yaping Chang |
| collection | DOAJ |
| description | Purpose. Medical cannabis for patients with chronic noncancer pain (CNCP) has been the focus of numerous health care recommendations. We conducted a systematic review to identify and summarize the currently available evidence-based recommendations. Methods. We searched MEDLINE, EMBASE, PsycINFO, the Cochrane database of systematic reviews, and websites for clinical guidelines and recommendations. We summarized the type of the publications, developers, approach of health care recommendation development, year and country of publication, and conditions that were addressed. We categorized the direction and strength of each recommendation. Results. We identified 12 eligible publications. Publication years ranged from 2007 to 2019; four (33.3%) of them were published in 2018. Canada ranked first for the number of publications (n = 4, 33.3%). Most (n = 11, 92%) of the included recommendations were based on both a systematic review of the best evidence and expert consensus. All the included publications provided a recommendation supporting medical cannabis for CNCP in general and for the specific conditions of neuropathic pain, chronic pain in people living with Human Immunodeficiency Virus (HIV), and chronic abdominal pain, with detailed information sharing and comprehensive consideration of a patient’s own values and preferences. Conclusion. Clinicians can attend to the guidance currently offered, being aware that only weak recommendations are available for medical cannabis in patients with CNCP, as a third- or fourth-line therapy. Detailed discussions with patients regarding the benefits in reducing pain and potential adverse effects are required before its prescription. |
| format | Article |
| id | doaj-art-606bfdf07e7f4720916e4134f7515d73 |
| institution | Kabale University |
| issn | 1203-6765 1918-1523 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-606bfdf07e7f4720916e4134f7515d732025-02-03T06:05:43ZengWileyPain Research and Management1203-67651918-15232021-01-01202110.1155/2021/88579488857948Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care RecommendationsYaping Chang0Meng Zhu1Christopher Vannabouathong2Raman Mundi3Roland S. Chou4Mohit Bhandari5OrthoEvidence Inc., Burlington, ON, CanadaOrthoEvidence Inc., Burlington, ON, CanadaOrthoEvidence Inc., Burlington, ON, CanadaDepartment of Surgery, University of Toronto, Toronto, ON, CanadaFaculty of Health Sciences, McMaster University, Hamilton, ON, CanadaOrthoEvidence Inc., Burlington, ON, CanadaPurpose. Medical cannabis for patients with chronic noncancer pain (CNCP) has been the focus of numerous health care recommendations. We conducted a systematic review to identify and summarize the currently available evidence-based recommendations. Methods. We searched MEDLINE, EMBASE, PsycINFO, the Cochrane database of systematic reviews, and websites for clinical guidelines and recommendations. We summarized the type of the publications, developers, approach of health care recommendation development, year and country of publication, and conditions that were addressed. We categorized the direction and strength of each recommendation. Results. We identified 12 eligible publications. Publication years ranged from 2007 to 2019; four (33.3%) of them were published in 2018. Canada ranked first for the number of publications (n = 4, 33.3%). Most (n = 11, 92%) of the included recommendations were based on both a systematic review of the best evidence and expert consensus. All the included publications provided a recommendation supporting medical cannabis for CNCP in general and for the specific conditions of neuropathic pain, chronic pain in people living with Human Immunodeficiency Virus (HIV), and chronic abdominal pain, with detailed information sharing and comprehensive consideration of a patient’s own values and preferences. Conclusion. Clinicians can attend to the guidance currently offered, being aware that only weak recommendations are available for medical cannabis in patients with CNCP, as a third- or fourth-line therapy. Detailed discussions with patients regarding the benefits in reducing pain and potential adverse effects are required before its prescription.http://dx.doi.org/10.1155/2021/8857948 |
| spellingShingle | Yaping Chang Meng Zhu Christopher Vannabouathong Raman Mundi Roland S. Chou Mohit Bhandari Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations Pain Research and Management |
| title | Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations |
| title_full | Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations |
| title_fullStr | Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations |
| title_full_unstemmed | Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations |
| title_short | Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations |
| title_sort | medical cannabis for chronic noncancer pain a systematic review of health care recommendations |
| url | http://dx.doi.org/10.1155/2021/8857948 |
| work_keys_str_mv | AT yapingchang medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations AT mengzhu medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations AT christophervannabouathong medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations AT ramanmundi medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations AT rolandschou medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations AT mohitbhandari medicalcannabisforchronicnoncancerpainasystematicreviewofhealthcarerecommendations |